Chutes & Ladders—Ex-Stanford president will lead new billion-dollar biotech

  Chutes and LaddersWelcome to this week’s Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your shop to Max Bayer or Gabrielle Masson, and we will feature it here at the end of each week.  

Ousted former Stanford president tapped to lead new billion-dollar biotech

Xaira Therapeutics

Last year was a difficult one for ex-Stanford president Marc Tessier-Lavigne, Ph.D. An investigation into his prior research from the campus’s student newspaper ultimately led to his resignation. But the once-chief scientific officer of Genentech is now back in biotech.  

Marc Tessier-lavigne

Marc Tessier-Lavigne, Ph.D.(Tessier-Lavigne Laboratory)

Tessier-Lavigne has been tapped to lead Xaira Therapeutics, which emerged this week with a whopping $1 billion (yes, with a “B”) in new capital to become a leader in AI’s use in drug discovery. That’s one of the…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks